Storia in 6 fonti

U.S. Obesity Rate Drops As GLP-1 Usage Grows

A new Gallup poll found about 11% of Americans were taking a GLP-1 medication for weight loss.

Raccontata da

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

forbes.comStai leggendo1 mese fa

U.S. Obesity Rate Drops As GLP-1 Usage Grows

A new Gallup poll found about 11% of Americans were taking a GLP-1 medication for weight loss.

originale

Timeline cronologica

lunedì 6 luglio 2026·nbcnews.com
New research aims to get closer to settling the fierce debate over what GLP-1s are worth
As a new Medicare program expands access to weight-loss drugs, high costs leave many who could benefit from them shut out.
martedì 7 luglio 2026·forbes.com
U.S. Obesity Rate Drops As GLP-1 Usage Grows
A new Gallup poll found about 11% of Americans were taking a GLP-1 medication for weight loss.

medicalxpress.com

1 mese fa

GLP-1 use hits record high as Medicare opens access to weight-loss drugs

The share of U.S. adults taking GLP-1 medications to lose weight has reached a record 11%.

Leggi questa versione → originale

gizmodo.com1 mese fa

11% of Americans Are Currently Taking a GLP-1 Weight Loss Drug Like Wegovy

15% of Americans have ever taken the drugs, up from 6% in 2024.

Leggi questa versione → originale

cnbc.com1 mese fa

Healthy Returns: Employers aren't expanding coverage of GLP-1 obesity drugs – many are finding ways around it

Around 36% of employers said they provide coverage of GLP-1s for both diabetes and weight loss, the same as 2025 and up from 34% in 2024, the survey said.

Leggi questa versione → originale

medpagetoday.com1 mese fa

Record High GLP-1 Use; Intense Interval Exercise; Endometriosis and Androgens

News and commentary from the endocrinology world

Leggi questa versione → originale

nbcnews.com1 mese fa

New research aims to get closer to settling the fierce debate over what GLP-1s are worth

As a new Medicare program expands access to weight-loss drugs, high costs leave many who could benefit from them shut out.

Leggi questa versione → originale

martedì 7 luglio 2026·

medpagetoday.com

Record High GLP-1 Use; Intense Interval Exercise; Endometriosis and Androgens

News and commentary from the endocrinology world

mercoledì 8 luglio 2026·

gizmodo.com

11% of Americans Are Currently Taking a GLP-1 Weight Loss Drug Like Wegovy

15% of Americans have ever taken the drugs, up from 6% in 2024.

mercoledì 8 luglio 2026·

cnbc.com

Healthy Returns: Employers aren't expanding coverage of GLP-1 obesity drugs – many are finding ways around it

Around 36% of employers said they provide coverage of GLP-1s for both diabetes and weight loss, the same as 2025 and up from 34% in 2024, the survey said.

giovedì 9 luglio 2026·

medicalxpress.com

GLP-1 use hits record high as Medicare opens access to weight-loss drugs

The share of U.S. adults taking GLP-1 medications to lose weight has reached a record 11%.